On March 12, Radboudumc and Radboud University have signed a letter of intent for intensified collaboration with Janssen.
This collaboration should enable researchers to link high-quality academic innovative research to the translation capabilities of industry even better. This will result in biomedical, pharmaceutical, and clinical research being available to patients more quickly.
Related news items
Innovation by Predica Diagnostics BV improves cervical cancer screening26 July 2022
A joint financing round from ION+2 and the Thematic Technology Transfer Medtech Fund (TTT Medtech) allows the further development of molecular diagnostic tests for different cancers by Predica Diagnostics (Nijmegen, NL).read more